REQUEST A DEMO
Total
USD $0.00
Search more companies

Trinity Pharmaceuticals & Food Private Limited (India)

Main Activities: Seafood Product Preparation and Packaging
Full name: Trinity Pharmaceuticals & Food Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Trinity Pharmaceuticals & Food Private Limited is an unlisted company, incorporated on 31/10/2012. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U15122MH2012PTC237336 and registration number is 237336. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Office No 813 B Wing Kanakia Wall Street Andheri Kurla Road Chakala Andheri East
Mumbai; Maharashtra; Postal Code: 400093

Contact Details: Purchase the Trinity Pharmaceuticals & Food Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Trinity Pharmaceuticals & Food Private Limited report to view the information.
Financial Auditors:
Purchase the Trinity Pharmaceuticals & Food Private Limited report to view the information.
Incorporation Date:
October 31, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Trinity Pharmaceuticals & Food Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.23%
Total operating revenue
-9.56%
Operating profit (EBIT)
67.24%
EBITDA
65.71%
Net Profit (Loss) for the Period
66.33%
Total Assets
-6.2%
Total Equity
46.67%
Operating Profit Margin (ROS)
3.66%
Net Profit Margin
2.59%
Return on Equity (ROE)
3.76%
Debt/Equity
-33.5%
Quick Ratio
1.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?